3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
27
Neoplasm Metastasis
9
Stomach Neoplasms
7
Ovarian Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Sarcoma
2
Salivary Gland Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
HER2-positive Gastric Cancer
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Advanced Solid Tumor
2
Advanced Breast Cancer
2
Adenocarcinoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Cisplatin
7
Radiation
6
pembrolizumab
5
Platinum
5
Biopsy
5
1,2-diaminocyclohexaneplatinum II citrate
5
Sentinel Lymph Node Biopsy
4
Drug Therapy
4
cemiplimab
3
X-Rays
3
Ultrasonography
3
Standard of Care
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Cetuximab
3
Carboplatin
3
Taxes
2
Surgical Procedures, Operative
2
Practice Guidelines as Topic
2
Photons
2
Paclitaxel
2
Interviews as Topic
2
trastuzumab deruxtecan
1
toripalimab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
sacituzumab govitecan
1
merphos
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mouth Neoplasms
×
trastuzumab deruxtecan
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled